Ramiah Investment Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Ramiah Investment Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$348K	Buy	+558	New	+$380K	0.27%	60
2025 Q2	–	Sell	-663	Closed	-$420K	–	67
2025 Q1	$420K	Buy	663 +179	+37%	+$123K	0.4%	41
2024 Q4	$345K	Buy	484 +17	+4%	+$14.3K	0.31%	54
2024 Q3	$491K	Sell	467 -321	-41%	-$357K	0.46%	46
2024 Q2	$828K	Buy	+788	New	+$764K	0.81%	21
2020 Q3	–	Sell	-2,009	Closed	-$1.25M	–	88
2020 Q2	$1.25M	Buy	+2,009	New	+$1.14M	1.32%	16

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

AIP

ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Ramiah Investment Group's REGN Position: Q2 2026 in Review

Ramiah Investment Group opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 558 shares worth $348K. The stake represents 0.27% of the portfolio and ranks #60 among its holdings. This is a return to the name: Ramiah Investment Group previously reported a position in REGN as recently as Q1 2025.

Ramiah Investment Group first reported a position in REGN in Q2 2020 and has held it in 6 quarters since. The position peaked at $1.25M in Q2 2020. 334 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Ramiah Investment Group held 558 shares of Regeneron Pharmaceuticals worth $348K as of Q2 2026.
Regeneron Pharmaceuticals was a new Ramiah Investment Group position in Q2 2026.
Regeneron Pharmaceuticals made up 0.27% of Ramiah Investment Group's portfolio in Q2 2026, its #60 holding.
Ramiah Investment Group first reported a position in Regeneron Pharmaceuticals in Q2 2020 and has held it in 6 quarters since.
Ramiah Investment Group's Regeneron Pharmaceuticals position peaked at $1.25M in Q2 2020.
334 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Ramiah Investment Group's 13F filing for Q2 2026, filed 16 Jul 2026.